Drugs / TG100-115
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00103350 | Jan 2005 → Dec 2006 | myocardial infarction | TargeGen | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TG100-115 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00103350 ↗ |
| Action | Inhibit | “PI3-kinase p110-gamma subunit inhibitor” CHEMBL230011 ↗1“PI3-kinase p110-delta subunit inhibitor” CHEMBL230011 ↗ |
| Modality | Small molecule | — CHEMBL230011 ↗ |
| Target | PIK3CD | “PI3-kinase p110-delta subunit inhibitor” CHEMBL230011 ↗ |
| Target | PIK3CG | “PI3-kinase p110-gamma subunit inhibitor” CHEMBL230011 ↗ |